The results showed that intracarotid (i.c.)B1R and B2R agonists significantly enhanced the uptake of DOX in tumor and/or surrounding normal brain tissues in F98 glioma-bearing rats compared to the vehicle-treated group (Figure 1A). The gene discussed is BDKRB2; the disease is central nervous system cancer.